111 related articles for article (PubMed ID: 1036923)
1. Pharmacological properties of thiazolinobutazone (LAS 11 871). III. General pharmacology, ulcerogenic effects and acute toxicity.
Colombo M; Márquez M; Roberts DJ
Arzneimittelforschung; 1976; 26(7):1347-56. PubMed ID: 1036923
[TBL] [Abstract][Full Text] [Related]
2. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
[No Abstract] [Full Text] [Related]
4. Pharmacological properties of thiazolinobutazone (LAS 11871). II. Analgesic and antipyretic effects.
Márquez M; Roberts DJ
Arzneimittelforschung; 1974 Nov; 24(11):1790-2. PubMed ID: 4480051
[No Abstract] [Full Text] [Related]
5. General pharmacological properties of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol (ditazol).
Caprino L; Borrelli F; Falchetti R
Arzneimittelforschung; 1973 Sep; 23(9):1283-7. PubMed ID: 4801221
[No Abstract] [Full Text] [Related]
6. General pharmacology of nizatidine in animals.
Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of the antiinflammatory agent 10-methylamine-11-H-indeno-[1,2-b]quinolin-11-one (MB432).
Chojnacka-Wójcik E; Naparzewska A
Pol J Pharmacol Pharm; 1983; 35(4):327-32. PubMed ID: 6607462
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
Zwagemakers JM; Claassen V
Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
[TBL] [Abstract][Full Text] [Related]
10. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological studies of a new antitussive, 1-phenethyl-4-hydroxy-salicylamido-4-methyl-piperidine-hydrochloride (S 1592) (author's transl)].
Duhault J; Tisserand F; Regnier G
Arzneimittelforschung; 1976 Apr; 26(4):516-23. PubMed ID: 989005
[TBL] [Abstract][Full Text] [Related]
12. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
13. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
14. General pharmacological properties of muroctasin.
Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
[TBL] [Abstract][Full Text] [Related]
15. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
16. [General pharmacology of a new substance derived from cinnamoyl piperazine. II. Action on general circulation and the autonomic nervous system. Other pharmacological properties].
Pourrias B; Dorme N; Bouvet P; Raynaud G
Therapie; 1971; 26(4):859-72. PubMed ID: 5119135
[No Abstract] [Full Text] [Related]
17. [Pharmacodynamic study of a new vasodilatator, cinepazide maleate. II. Action on general and cardiac hemodynamics, respiration and diuresis. Local anesthetic action and effect on the autonomic nervous system. Prolonged toxicity].
Pourrias B; Bailly Y; Sergant M; Bouvet P; Raynaud G
Therapie; 1974; 29(1):43-50. PubMed ID: 4849378
[No Abstract] [Full Text] [Related]
18. The preparation and pharmacological selection of a new anti-inflammatory agent, thiazolinobutazone.
Moragues J; Thiele K; Márquez M; Colombo M; Roberts DJ
Arzneimittelforschung; 1974 Nov; 24(11):1785-6. PubMed ID: 4480049
[No Abstract] [Full Text] [Related]
19. Pharmacological properties of thiazolinobutazone (LAS 11871). I. Anti-inflammatory effects.
Márquez M; Roberts DJ
Arzneimittelforschung; 1974 Nov; 24(11):1786-9. PubMed ID: 4480050
[No Abstract] [Full Text] [Related]
20. [Pharmacological study on thiocarboxamides with antisecretory and ulceroprotective properties].
Pascaud X; Laubie M
Arzneimittelforschung; 1971 Oct; 21(10):1547-53. PubMed ID: 5171884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
